Menu

  • Home
Skip to content

John Barleycorn

All the news they won't print.

generics

Drug companies are sitting on generics—43% of recently approved aren’t for sale | Ars Technica

Posted on February 11, 2019 by johnbarleycorn12

You pay more for medicine because hundreds of generics aren’t for sale.
— Read on arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/

Big pharma again.

Blog at WordPress.com.
  • Subscribe Subscribed
    John Barleycorn
    Join 779 other subscribers

    Have a WordPress.com account? Log in now.

  • John Barleycorn
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar